XXI International Workshop on Chronic Lymphocytic Leukemia (iwCLL)

XXI International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is organized by Bio Ascend LLC and will be held from Sep 12 - 15, 2025 at ICE Krakow Congress Centre, Krakow, Lesser Poland, Poland.

Description:
The International Workshop on Chronic Lymphocytic Leukemia™ (iwCLL) is a premier four-day biennial event dedicated exclusively to enhancing knowledge and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Focused on advancing both cutting-edge and emerging concepts in the biology and management of this blood cancer, iwCLL stands as the largest global gathering of its kind. The workshop fosters collaboration and the exchange of expertise among leading researchers, clinicians, and scientists from around the world.

Educational Objectives:
Upon completion of this activity, participants should be able to:

• (YIM) Evaluate and interpret the clinical significance of emerging preclinical and clinical evidence regarding:
  • Factors contributing to the pathogenesis of CLL
  • The diagnosis, prognosis, and initial treatment of CLL
  • Contributors to disease progression and Richter’s transformation
• Assess the clinical trial results of current and emerging treatment strategies for patients with newly diagnosed CLL
• Evaluate the latest safety and efficacy data of approved and investigational approaches for patients with relapsed/refractory CLL
• Recognize best practices to achieve optimal outcomes among patients with CLL, including treating patients with high-risk disease, minimizing adverse events, and preventing progression of disease
• Review how the genomics, proteomics, and epigenetics of CLL play a role in the pathogenesis of disease
• Discuss optimal approaches to the identification and treatment of patients who develop Richter’s transformation
• Identify unique patient-related and disease-related factors that influence the care of patients with CLL, including vaccination, infection prevention, diet and exercise, and patient comorbidities
• Examine global perspectives and approaches for caring for patients with CLL, including access to care